Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision history now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2. This is an administrative update to the page metadata and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded metadata entries including the keyword 'Pathogenesis of COVID-19 from a cell biologic perspective' and sponsor-related notes ('APR Applied Pharma Research s.a.'; 'Helpful Links Provided by APR'), and updated the revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check33 days agoChange DetectedRemoved the 'Pathogenesis of COVID-19 from a cell biologic perspective' section and the sponsor/credit information for APR Applied Pharma Research s.a., as well as the 'Helpful Links Provided by' label from the study page.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision update: v3.5.0 replaces the previous v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor technical update with no substantive changes to the study details.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision: v3.4.2 is now displayed, indicating updated content for the study page. The government funding/operating status notice was removed.SummaryDifference0.4%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.